HOME >> BIOLOGY >> NEWS
The search for a kinder, gentler chemotherapy

Painful and damaging chemotherapy may one day be a thing of the past. Researchers at the Georgia Institute of Technology and Purdue University have developed nano-sized particles that can target and trick cancer cells into absorbing them. Once inside, the particles may soon be able to deliver a pharmaceutical payload, killing the tumor from within, avoiding the destruction of healthy cells responsible for much of the damage caused by traditional chemotherapy. The research is published in the August 25 edition of the Journal of the American Chemical Society.

"We've developed a class of particles called core/shell nanogels that we can functionalize with a specific kind of chemistry that allows them to target cancer cells," said L. Andrew Lyon, associate professor at Georgia Tech's School of Chemistry and Biochemistry.

That specific kind of chemistry is folic acid. Cancer cells have more receptors for folic acid and absorb more of the nutrient than healthy cells. In a process akin to hiding a dog's heartworm pill in a glob of peanut butter, researchers covered the surface of the nanogels with folic acid, disguising the particles as an essential nutrient. Once the cancer cells took the particles in, researchers increased the temperature of the cells, causing the particles to clump together and shrink, killing the cell.

Heating the cell is a crucial step in triggering the particles to destroy cells, but it's also a safeguard. Cancer cells have more folic acid receptors than normal cells, but normal cells could still absorb the nanoparticles. By applying a targeted heat source - like ultrasound - only to the tumor, doctors should be able to avoid killing healthy cells that happen to take in the nanoparticles.

"The possibility for using these nanoparticles as vehicles to target and kill only cancer cells is particularly exciting," said Jean Chmielewski, professor of chemistry at Purdue University. "Decorating the exterior of the vehicle with
'"/>

Contact: David Terraso
david.terraso@icpa.gatech.edu
404-385-2966
Georgia Institute of Technology
9-Sep-2004


Page: 1 2

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. Landmark agreement between Samoa and UC Berkeley could help search for AIDS cure
3. Researchers determine genetic cause of Timothy syndrome
4. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
5. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
6. Belgian researchers explore revolutionary approach to angiogenesis
7. Researchers find color sensitive atomic switch in bacteria
8. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
9. Award winning researchers reveal potential new role for Glivec
10. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
11. Researchers identify protein promoting vascular tumor growth

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... , ... September 30, 2019 , ... ... focused on molecular manufacturing and other transformative technologies, announced the winners for the ... Experiment and the other for Theory in nanotechnology/molecular manufacturing. , Established in 1993 ...
(Date:9/30/2019)... ... September 30, 2019 , ... As human induced pluripotent stem ... for studying the development and diseases of the human heart, there is an increasing ... progeny heart muscle cells to be clearly and easily recorded. A study released today ...
(Date:9/30/2019)... Calif. (PRWEB) , ... September ... ... a leading think tank, research, and public interest organization focused on molecular ... Distinguished Student Prize. , The Award recognizes the College graduate or undergraduate ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 01, 2019 , ... Today ... itself, announced the midway point of its randomized research trial for individuals with ... to measure the efficacy of a non-invasive technology which compares tones delivered to ...
(Date:10/3/2019)... ... October 02, 2019 , ... Murrieta Genomics , the launch ... venture capital companies in Silicon Valley at a special Life Science showcase event ... be held at the JJ Lake Business Center located at 340 E. Middlefield Road ...
(Date:10/3/2019)... ... ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New England ... Ph.D., discussed important design factors that currently limit the success of early stage stem ... clinical trials, in his talk Dr. Sherley focused on the highly problematic ...
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as one ... with MRSA becoming one of the most serious concerns. Hong Kong cannot be spared ... community-associated MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the year ...
Breaking Biology Technology:
Cached News: